InfuSystem Holdings, Inc

Name: InfuSystem Holdings, Inc standardized financial statements, quarterly
Creator: Listed

INFUNYSECIK 1337013HealthcareFiscal year ends Dec 31

Share this page

Link

Story card, 1080 × 1920

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$36.9m, Q2 FY2026

Operating income$4.2m, Q2 FY2026

Net income$3.2m, Q2 FY2026

InfuSystem Holdings, Inc, income statement, quarterly
Line item	Unit	Q3 FY20232023-09-30	Q4 FY20232023-12-31	Q1 FY20242024-03-31	Q2 FY20242024-06-30	Q3 FY20242024-09-30	Q4 FY20242024-12-31	Q1 FY20252025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	Q4 FY20252025-12-31	Q1 FY20262026-03-31	Q2 FY20262026-06-30
Revenue	$m	31.9	31.8	32.0	33.7	35.3	33.8	34.7	36.0	36.5	36.2	33.7	36.9
Cost of revenue	$m	16.3	15.1	15.5	17.0	16.3	15.6	15.5	16.1	15.7	15.8	14.0	15.5
Gross profit	$m	15.6	16.7	16.5	16.7	19.0	18.2	19.2	19.9	20.8	20.4	19.7	21.4
Operating income	$m	1.7	1.3	(0.8)	1.9	3.3	2.6	0.6	3.8	3.8	3.7	1.6	4.2
Interest expense	$m	0.6	0.5	0.5	0.5	0.5	0.4	0.3	0.4	0.3	0.3	0.3	0.3
Income tax	$m	0.4	0.7	(0.2)	0.6	1.0	1.3	0.5	0.8	1.2	1.5	0.4	0.6
Net income	$m	0.7	0.1	(1.1)	0.7	1.8	0.9	(0.3)	2.6	2.3	2.0	1.0	3.2
Diluted EPS	$ per share	0.03	not reported	(0.05)	0.03	0.08	not reported	(0.01)	0.12	0.11	not reported	0.05	0.15
Basic EPS	$ per share	0.03	not reported	(0.05)	0.03	0.08	not reported	(0.01)	0.12	0.11	not reported	0.05	0.16

Balance sheet

Cash and equivalents$964.0k, Q2 FY2026

Long-term debt$20.4m, Q2 FY2026

Shareholders' equity$59.1m, Q2 FY2026

InfuSystem Holdings, Inc, balance sheet, quarterly
Line item	Unit	Q3 FY20232023-09-30	FY20232023-12-31	Q1 FY20242024-03-31	Q2 FY20242024-06-30	Q3 FY20242024-09-30	FY20242024-12-31	Q1 FY20252025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	FY20252025-12-31	Q1 FY20262026-03-31	Q2 FY20262026-06-30
Cash and equivalents	$m	0.2	0.2	0.8	0.1	0.4	0.5	1.5	0.7	1.0	3.2	2.1	1.0
Current assets	$m	29.7	30.6	32.5	32.9	33.6	32.2	35.3	34.8	35.6	36.3	36.7	38.3
Total assets	$m	102	103	105	109	105	104	104	101	98.9	101	98.7	97.7
Current liabilities	$m	14.3	15.7	17.3	15.9	16.9	17.7	16.0	15.9	18.7	20.2	17.1	15.3
Total liabilities	$m	50.6	50.6	52.6	55.0	49.8	46.1	49.1	46.3	43.4	43.2	39.9	38.6
Long-term debt	$m	32.7	29.1	29.9	34.2	28.0	23.9	28.7	26.3	20.9	19.6	19.6	20.4
Current portion of debt	$m	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Shareholders' equity	$m	51.5	52.3	52.3	53.5	55.5	57.5	55.1	54.5	55.5	57.3	58.7	59.1

Cash flow

Operating cash flow$6.8m, Q2 FY2026

Capital expenditure$91.0k, Q2 FY2026

Share repurchases$3.5m, Q2 FY2026

InfuSystem Holdings, Inc, cash flow, quarterly
Line item	Unit	Q3 FY20232023-09-30	Q4 FY20232023-12-31	Q1 FY20242024-03-31	Q2 FY20242024-06-30	Q3 FY20242024-09-30	Q4 FY20242024-12-31	Q1 FY20252025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	Q4 FY20252025-12-31	Q1 FY20262026-03-31	Q2 FY20262026-06-30
Operating cash flow	$k	4,264	4,658	377	2,309	9,842	7,931	1,780	7,009	8,493	7,126	970	6,777
Capital expenditure	$k	122	408	182	337	43.0	530	131	217	79.0	133	157	91.0
Share repurchases	$k	0.0	0.0	0.0	283	698	199	2,895	3,500	2,168	1,306	809	3,549

Diluted shares (weighted)20.92m, Q2 FY2026

InfuSystem Holdings, Inc, shares, quarterly
Line item	Unit	Q3 FY20222022-09-30	Q1 FY20232023-03-31	Q2 FY20232023-06-30	Q3 FY20232023-09-30	Q1 FY20242024-03-31	Q2 FY20242024-06-30	Q3 FY20242024-09-30	Q1 FY20252025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	Q1 FY20262026-03-31	Q2 FY20262026-06-30
Diluted shares (weighted)	m shares	21.5	20.9	21.6	21.7	21.2	21.7	21.7	21.1	21.1	20.9	20.9	20.9

Shares outstanding: 19.92m at Jul 31, 2026, from the cover of the 10-Q filed Aug 4, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:37 ET. Listed shows no prices and gives no investment advice.